company

VAXA GROUP AS

1366 LYSAKER

Return on Equity
66,65 %
Current Ratio
1,35
Debt-to-Equity Ratio
0,02
Key figures (NOK)2022
Revenue0
Net Income2 306 000
Total Assets6 302 000
Total Equity3 460 000
Income (NOK)2022
Revenue0
Expenditure417 000
Operating Profit−417 000
Financial Income2 733 000
Financial Costs0
Financial Balance2 733 000
Earnings Before Tax2 316 000
Tax10 000
Net Income2 306 000
Balance (NOK)2022
Total Fixed Assets2 555 000
Total Current Assets3 746 000
Total Assets6 302 000
Total Retained Equity954 000
Total Equity3 460 000
Total Long-Term Debt71 000
Total Current Debt2 771 000
Total Equity and Debt6 302 000
Cash flow (NOK)2022
Sales Income0
Other Income0
Revenue0
Cost of Goods Sold0
Salary Costs378 000
Depreciation0
Impairment0
Expenditure417 000
Operating Profit−417 000
Financial Income2 733 000
Financial Costs0
Financial Balance2 733 000
Dividends2 600 000
Net Income2 306 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets0
Total Fiancial Fixed Assets2 555 000
Total Fixed Assets2 555 000
Stock0
Total Investments0
Cash, Bank999 000
Total Current Assets3 746 000
Total Assets6 302 000
Total Equity3 460 000
Short-Term Group Debt0
Total Long-Term Debt71 000
Creditors23 000
Unpaid Taxes0
Dividends2 600 000
Other Current Debt138 000
Total Current Debt2 771 000
Total Equity and Debt6 302 000
Financial indicators2022
Return on Equity66,65 %
Debt-to-Equity Ratio0,02
Operating Profit Margin-
Current Ratio1,35
Quick Ratio1,35
Equity Ratio0,55
Gross Profit Margin-
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English